Laurence Birch serves as Executive at NEOPHARM INC, where they oversee executive responsibilities. Since joining the company, Laurence Birch has executed 9 insider transactions totaling $10.3K, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 12, 2009 involved purchasing 15,000 shares valued at $750.
Laurence Birch currently holds 227,556 shares of NEOPHARM INC (NEOL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Laurence Birch has been a net buyer of NEOL stock. They have purchased $10.3K and sold $0 worth of shares.
Laurence Birch's most recent insider trade was on Mar 12, 2009, when they purchased 15,000 shares at $0.05 per share.
Get notified when new Form 4 filings are submitted
| $0.04 |
| Discretionary |
| Mar 11, 2009 | NEOL.PK | $595 | Purchase | 11,901 | $0.05 | Discretionary |
| Jun 3, 2008 | DATA | $2.7K | Purchase | 5,000 | $0.54 | Discretionary |
| May 27, 2008 | NEOL | $5.3K | Purchase | 9,000 | $0.59 | Discretionary |
| May 27, 2008 | NEOL | $590 | Purchase | 1,000 | $0.59 | Discretionary |
| Aug 13, 2007 | DATA | $10.5K | Award | 3,443 | $3.05 | Discretionary |
| Jun 19, 2007 | NEOL | $0 | Award | 180,665 | $N/A | Discretionary |
| May 14, 2007 | DATA | $6.0K | Award | 1,193 | $5.03 | Discretionary |